The early dissemination defect attributed to disruption of decorin-binding proteins is abolished in chronic murine lyme borreliosis

Infection and Immunity

Volumn 81, Issue 5, 2013, Pages 1663-1673

  Imai, Denise M ^a   Scott Samuels, D ^b   Feng, Sunlian ^a   Hodzic, Emir ^a   Olsen, Kim ^a   Barthold, Stephen W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MONTANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BORRELIA BURGDORFERI; CHRONICITY; CONTROLLED STUDY; FEMALE; LYME DISEASE; LYMPHATIC SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; SPIROCHETE;

ADAPTIVE IMMUNITY; ADHESINS, BACTERIAL; ANIMALS; BACTERIAL ADHESION; BORRELIA BURGDORFERI; CHRONIC DISEASE; FEMALE; IMMUNOCOMPROMISED HOST; LYME DISEASE; LYMPH NODES; MICE; MICE, SCID;

EID: 84877798458     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01359-12     Document Type: Article

References (59)

1. Brissette CA, Verma A, Bowman A, Cooley AE, Stevenson B. 2009. The Borrelia burgdorferi outer-surface protein ErpX binds mammalian laminin. Microbiology 155:863-872.
2. Brissette CA, Bykowski T, Cooley AE, Bowman A, Stevenson B. 2009. Borrelia burgdorferi RevA antigen binds host fibronectin. Infect. Immun. 77:2802-2812.
3. Coburn J, Chege W, Magoun L, Bodary SC, Leong JM. 1999. Characterization of the candidate Borrelia burgdorferi 3-chain integrin ligand identified using a phage display library. Mol. Microbiol. 34:926-940.
4. Fischer JR, Parveen N, Magoun L, Leong JM. 2003. Decorin-binding proteins A and B confer distinct mammalian cell type-specific attachment by Borrelia burgdorferi, the Lyme disease spirochete. Proc. Natl. Acad. Sci. U. S. A. 100:7307-7312.
5. Fischer JR, LeBlanc KT, Leong JM. 2006. Fibronectin binding protein BBK32 of the Lyme disease spirochete promotes bacterial attachment to glycosaminoglycans. Infect. Immun. 74:435-441.
6. Guo BP, Norris SJ, Rosenberg LC, Höök M. 1995. Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect. Immun. 63:3467-3472.
7. Parveen N, Leong JM. 2000. Identification of a candidate glycosaminoglycan-binding adhesin of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 35:1220-1234.
8. Antonara S, Ristow L, Coburn J. 2011. Adhesion mechanisms of Borrelia burgdorferi. Adv. Exp. Med. Biol. 715:35-49.
9. Zambrano MC, Beklemisheva AA, Bryksin AV, Newman SA, Cabello FC. 2004. Borrelia burgdorferi binds to, invades, and colonizes native type I collagen lattices. Infect. Immun. 72:3138-3146.
10. Antonara S, Chafel RM, LaFrance M, Coburn J. 2007. Borrelia burgdorferi adhesins identified using in vivo phage display. Mol. Microbiol. 66: 262-276.
11. Hagman KE, Lahdenne P, Popova TG, Porcella SF, Akins DR, Radolf JD, Norgard MV. 1998. Decorin-binding protein of Borrelia burgdorferi is encoded within a two-gene operon and is protective in the murine model of Lyme borreliosis. Infect. Immun. 66:2674-2683.
12. Feng S, Hodzic E, Stevenson B, Barthold SW. 1998. Humoral immunity to Borrelia burgdorferi N40 decorin binding proteins during infection in laboratory mice. Infect. Immun. 66:2827-2835.
13. Guo BP, Brown EL, Dorward DW, Rosenberg LC, Höök M. 1998. Decorin-binding adhesins from Borrelia burgdorferi. Mol. Microbiol. 30: 711-723.
14. Hanson MS, Cassatt DR, Guo BP, Patel NK, McCarthy MP, Dorward DW, Höök M. 1998. Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection. Infect. Immun. 66:2143-2153.
15. Benoit VM, Fischer JR, Lin Y, Parveen N, Leong JM. 2011. Allelic variation of the Lyme disease spirochete adhesin DbpA influences spirochetal binding to decorin, dermatan sulfate, and mammalian cells. Infect. Immun. 79:3501-3509.
16. Roberts WC, Mullikin BA, Lathigra R, Hanson MS. 1998. Molecular analysis of sequence heterogeneity among genes encoding decorin binding proteins A and B of Borrelia burgdorferi sensu lato. Infect. Immun. 66: 5275-5285.
17. Salo J, Loimaranta V, Lahdenne P, Viljanen MK, Hytönen J. 2011. Decorin binding by DbpA and B of Borrelia garinii, Borrelia afzelii and Borrelia burgdorferi sensu stricto. J. Infect. Dis. 204:65-73.
18. Hodzic E, Feng S, Freet KJ, Barthold SW. 2003. Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice. Infect. Immun. 71:5042-5055.
19. Cassatt DR, Patel NK, Ulbrandt ND, Hanson MS. 1998. DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies. Infect. Immun. 66:5379-5387.
20. Tunev SS, Hastey CJ, Hodzic E, Feng S, Barthold SW, Baumgarth N. 2011. Lymphadenopathy during Lyme borreliosis is caused by spirochete migration-induced specific B cell activation. PLoS Pathog. 7:e1002066. doi:10.1371/journal.ppat.1002066.
21. Shi Y, Xu Q, McShan K, Liang FT. 2008. Both decorin-binding proteins A and B are critical for the overall virulence of Borrelia burgdorferi. Infect. Immun. 76:1239-1246.
22. Shi Y, Xu Q, Seemanaplli SV, McShan K, Liang FT. 2008. Common and unique contributions of decorin-binding proteins A and B to the overall virulence of Borrelia burgdorferi. PLoS One 3:e3340. doi:10.1371/journal.pone.0003340.
23. Shi Y, Xu Q, Seemanaplli SV, McShan K, Liang FT. 2006. The dbpBA locus of Borrelia burgdorferi is not essential for infection of mice. Infect. Immun. 74:6509-6512.
24. Blevins JS, Hagman KE, Norgard MV. 2008. Assessment of decorinbinding protein A to the infectivity of Borrelia burgdorferi in the murine models of needle and tick infection. BMC Microbiol. 8:82.
25. Weening EH, Parveen N, Trzeciakowski JP, Leong JM, Höök M, Skare JT. 2008. Borrelia burgdorferi lacking DbpBA exhibits an early survival defect during experimental infection. Infect. Immun. 76:5694-5705.
26. Motameni AT, Bates TC, Juncadella IJ, Petty C, Hedrick MN, Anguita J. 2005. Distinct bacterial dissemination and disease outcome in mice subcutaneously infected with Borrelia burgdorferi in the midline of the back and the footpad. FEMS Immunol. Med. Microbiol. 45:279-284.
27. Shih CM, Pollack RJ, Telford SR, Spielman A. 1992. Delayed dissemination of Lyme disease spirochetes from the site of deposition in the skin of mice. J. Infect. Dis. 4:827-831.
28. Shih CM, Telford SR, Pollack RJ, Spielman A. 1993. Rapid dissemination by the agent of Lyme disease in hosts that permit fulminating infection. Infect. Immun. 61:2396-2399.
29. Wormser GP. 2006. Hematogenous dissemination in early Lyme disease. Wien. Klin. Wochenschr. 118:634-637.
30. Barthold SW, Persing DH, Armstrong AL, Peeples RA. 1991. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am. J. Pathol. 139:263-273.
31. Norman UM, Moriarty TJ, Dresser AR, Millen B, Kubes P, Chaconas G. 2008. Molecular mechanisms involved in vascular interactions of the Lyme disease pathogen in a living host. PLoS Pathog. 4:e1000169. doi:10.1371/journal.ppat.1000169.
32. Straubinger RK, Straubinger AF, Härter L, Jacobson RH, Chang Y, Summers BA, Erb HN, Appel MJG. 1997. Borrelia burgdorferi migrates into joint capsules and causes up-regulation of interleukin-8 in synovial membranes of dogs experimentally infected with ticks. Infect. Immun. 65:1273-1285.
33. Casjens S, Palmer N, van Vugt R, Huang WM, Stevenson B, Rosa P, Lathigra R, Sutton G, Peterson J, Dodson RJ, Haft D, Hickey E, Gwinn M, White O, Fraser CM. 2000. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 35: 490-516.
34. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, White O, Ketchum KA, Dodson R, Hickey EK, Gwinn M, Dougherty B, Tomb J, Fleischmann RD, Richardson D, Peterson J, Kerlavage AR, Quakenbush J, Salzberg S, Hanson M, van Vugt R, Palmer N, Adams MD, Gocayne J, Weidman J, Utterback T, Watthey L, McDonald L, Artiach P, Bowman C, Garland S, Fujii C, Cotton MD, Horst K, Roberts K, Hatch B, Smith HO, Venter JC. 1997. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580-586.
35. Elias AF, Stewart PE, Grimm D, Caimano MJ, Eggers CH, Tilly K, Bono JL, Akins DR, Radolf JD, Schwan TG, Rosa P. 2002. Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background. Infect. Immun. 70:2139-2150.
36. Frank KL, Bundle SF, Kresge ME, Eggers CH, Samuels DS. 2003. aadA confers streptomycin-resistance in Borrelia burgdorferi. J. Bacteriol. 185: 6723-6727.
37. Samuels DS. 1995. Electrotransformation of the spirochete Borrelia burgdorferi. Methods Mol. Biol. 47:253-259.
38. Barbour AG. 1984. Isolation and cultivation of Lyme disease spirochetes. Yale J. Biol. Med. 57:521-525.
39. Casjens SR, Mongodin EF, Qui WG, Luft BJ, Schutzer SE, Gilcrease EB, Huang WM, Vujadinovic M, Aron JK, Vargas LC, Freeman S, Radune D, Weidman JF, Dimitrov GI, Khouri HM, Sosa JE, Halpin RA, Dunn JJ, Fraser CM. 2012. Genome stability of Lyme disease spirochetes: comparative genomics of Borrelia burgdorferi plasmids. PLoS One 7:e33280. doi:10.1371/journal.pone.0033280.
40. Armstrong AL, Barthold SW, Persing DH, Beck DS. 1992. Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am. J. Trop. Med. Hyg. 47:249-258.
41. Barthold SW, Hodzic E, Tunev S, Feng S. 2006. Antibody-mediated disease remission in the mouse model of Lyme borreliosis. Infect. Immun. 74:4817-4825.
42. Barthold SW. 1991. Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice. J. Infect. Dis. 163:419-420.
43. Barthold SW, de Souza MS, Janotka JL, Smith AL, Persing DH. 1993. Chronic Lyme borreliosis in the laboratory mouse. Am. J. Pathol. 143: 959-971.
44. Cabello FC, Godfrey HP, Newman SA. 2007. Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix. Trends Microbiol. 15: 350-354.
45. Parveen N, Cornell KA, Bono JL, Chamberland C, Rosa P, Leong JM. 2006. Bgp, a secreted glycosaminoglycan-binding protein of Borrelia burgdorferi strain N40, displays nucleosidase activity and is not essential for infection of immunodeficient mice. Infect. Immun. 74:3016-3020.
46. Li X, Liu X, Beck DS, Kantor FS, Fikrig E. 2006. Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity. Infect. Immun. 74:3305-3313.
47. Seshu J, Esteve-Gassent MD, Labandeira-Rey M, Kim JH, Trzeciakowski JP, Höök M, Skare JT. 2006. Inactivation of the fibronectinbinding adhesion gene bbk32 significantly attenuates the infectivity potential of Borrelia burgdorferi. Mol. Microbiol. 59:1591-1601.
48. Coburn J, Cugini C. 2003. Targeted mutation of the outer membrane protein P66 disrupts attachment of the Lyme disease agent, Borrelia burgdorferi, to integrin v3. Proc. Natl. Acad. Sci. U. S. A. 100:7301-7306.
49. Ristow LC, Miller HE, Padmore LJ, Chettri R, Salzman N, Caimano MJ, Rosa PA, Coburn J. 2012. The 3-integrin ligand of Borrelia burgdorferi is critical for infection of mice but not ticks. Mol. Microbiol. 85:1105-1118.
50. Hastey CJ, Elsner RA, Barthold SW, Baumgarth N. 2012. Delays and diversions mark the development of B cell responses to Borrelia burgdorferi infection. J. Immunol. 188:5612-5622.
51. Barthold SW, deSouza M, Feng S. 1996. Serum-mediated resolution of Lyme arthritis in mice. Lab. Invest. 74:57-67.
52. McKisic MD, Redmond WL, Barthold SW. 2000. T cell-mediated pathology in murine Lyme borreliosis. J. Immunol. 164:6096-6099.
53. Schaible UE, Wallich R, Kramer MD, Nerz G, Stehle T, Museteanu C, Simon MM. 1994. Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone. Int. Immunol. 6:671-681.
54. Murphy K, Travers P, Walport M. 2008. Janeway's immunobiology, 7th ed, p 400-401. Garland Science, New York, NY.
55. Liang FT, Brown EL, Wang T, Iozzo RV, Fikrig E. 2004. Protective niche for Borrelia burgdorferi to evade humoral immunity. Am. J. Pathol. 165: 977-985.
56. Strother KO, Hodzic E, Barthold SW, de Silva AM. 2007. Infection of mice with Lyme disease spirochetes constitutively producing outer surface protein A and B. Infect. Immun. 75:2786-2794.
57. Hawley K, Navasa N, Olson CM, Jr, Bates TC, Garg R, Hedrick MN, Conze D, Rincon M, Anguita J. 2012. Macrophage p38 mitogenactivated protein kinase activity regulates invariant natural killer T-cell responses during Borrelia burgdorferi infection. J. Infect. Dis. 206:283-291.
58. Lee WY, Moriarty TJ, Wong CH, Zhou H, Strieter RM, van Rooijen N, Chaconas G, Kubes P. 2010. An intravascular immune response to Borrelia burgdorferi involves Kupffer cells and iNKT cells. Nat. Immunol. 11:295-302.
59. Xu Q, McShan K, Liang FT. 2008. Essential protective role attributed to the surface lipoproteins of Borrelia burgdorferi against innate defences. Mol. Microbiol. 69:15-29.